Ascendis Pharma
ASND
#1547
Rank
โ‚น1.219 T
Marketcap
โ‚น19,963
Share price
4.88%
Change (1 day)
75.20%
Change (1 year)

Earnings for Ascendis Pharma (ASND)

Earnings in 2025 (TTM): -โ‚น12.42 Billion

According to Ascendis Pharma 's latest financial reports the company's current earnings are โ‚น0.72 Billion. In 2024 the company made an earning of -โ‚น26.01 Billion, an increase over its 2023 earnings that were of -โ‚น41.36 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ascendis Pharma from 2014 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น12.42 Billion-52.24%
2024 -โ‚น26.01 Billion-37.13%
2023 -โ‚น41.36 Billion-13.46%
2022 -โ‚น47.79 Billion23.12%
2021 -โ‚น38.82 Billion-10.49%
2020 -โ‚น43.37 Billion104.55%
2019 -โ‚น21.2 Billion61.09%
2018 -โ‚น13.16 Billion1.03%
2017 -โ‚น13.03 Billion89.6%
2016 -โ‚น6.88 Billion104.12%
2015 -โ‚น3.37 Billion185.04%
2014 -โ‚น1.19 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Advaxis
ADXS
-โ‚น3.09 Billion-76.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
-โ‚น6.93 Billion-46.67%๐Ÿ‡ฉ๐Ÿ‡ช Germany
Akebia Therapeutics
AKBA
-โ‚น1.39 Billion-89.34%๐Ÿ‡บ๐Ÿ‡ธ USA